{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T03:05:14Z","timestamp":1776395114934,"version":"3.51.2"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011710","name":"Shaanxi Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2019KW- 079"],"award-info":[{"award-number":["2019KW- 079"]}],"id":[{"id":"10.13039\/501100011710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970329"],"award-info":[{"award-number":["81970329"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aims<\/jats:title>\n                <jats:p>Type 2 diabetes mellitus (T2DM) is now very prevalent in China. Due to the lower rate of controlled diabetes in China compared to that in developed countries, there is a higher incidence of serious cardiovascular complications, especially acute coronary syndrome (ACS). The aim of this study was to establish a potent risk predictive model in the economically disadvantaged northwest region of China, which could predict the probability of new-onset ACS in patients with T2DM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Of 456 patients with T2DM admitted to the First Affiliated Hospital of Xi\u2019an Jiaotong University from January 2018 to January 2019 and included in this study, 270 had no ACS, while 186 had newly diagnosed ACS. Overall, 32 demographic characteristics and serum biomarkers of the study patients were analysed. The least absolute shrinkage and selection operator regression was used to select variables, while the multivariate logistic regression was used to establish the predictive model that was presented using a nomogram. The area under the receiver operating characteristics curve (AUC) was used to evaluate the discriminatory capacity of the model. A calibration plot and Hosmer\u2013Lemeshow test were used for the calibration of the predictive model, while the decision curve analysis (DCA) was used to evaluate its clinical validity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After random sampling, 319 and 137 T2DM patients were included in the training and validation sets, respectively. The predictive model included age, body mass index, diabetes duration, systolic blood pressure (SBP), diastolic blood pressure (DBP), low-density lipoprotein cholesterol, serum uric acid, lipoprotein(a), hypertension history and alcohol drinking status as predictors. The AUC of the predictive model and that of the internal validation set was 0.830 [95% confidence interval (CI) 0.786\u20130.874] and 0.827 (95% CI 0.756\u20130.899), respectively. The predictive model showed very good fitting degree, and DCA demonstrated a clinically effective predictive model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>A potent risk predictive model was established, which is of great value for the secondary prevention of diabetes. Weight loss, lowering of SBP and blood uric acid levels and appropriate control for DBP may significantly reduce the risk of new-onset ACS in T2DM patients in Northwest China.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00592-020-01484-x","type":"journal-article","created":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T19:02:36Z","timestamp":1580583756000},"page":"705-713","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["A potent risk model for predicting new-onset acute coronary syndrome in patients with type 2 diabetes mellitus in Northwest China"],"prefix":"10.1007","volume":"57","author":[{"given":"Jun","family":"Lyu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiyi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxian","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-Wei","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9736-2440","authenticated-orcid":false,"given":"Qingbin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,1]]},"reference":[{"key":"1484_CR1","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1007\/s00125-005-1858-4","volume":"48","author":"HC Gerstein","year":"2005","unstructured":"Gerstein HC, Pogue J, Mann JFE, Lonn E, Dagenais GR, McQueen M et al (2005) The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis. Diabetologia 48:1749\u20131755","journal-title":"Diabetologia"},{"key":"1484_CR2","first-page":"145","volume":"8","author":"Z Punthakee","year":"2007","unstructured":"Punthakee Z, Werstuck GH, Gerstein HC (2007) Diabetes and cardiovascular disease: explaining the relationship. Rev Cardiovasc Med 8:145\u2013153","journal-title":"Rev Cardiovasc Med"},{"key":"1484_CR3","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.2337\/dc12-0977","volume":"36","author":"Y Xu","year":"2013","unstructured":"Xu Y, Bi Y, Li M, Wang T, Sun K, Xu M et al (2013) Significant coronary stenosis in asymptomatic Chinese with different glycemic status. Diabetes Care 36:1687\u20131694","journal-title":"Diabetes Care"},{"issue":"925","key":"1484_CR4","first-page":"e11","volume":"126","author":"L Ji","year":"2013","unstructured":"Ji L, Hu D, Pan C, Weng J, Huo Y, Ma C et al (2013) Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients. Am J Med 126(925):e11\u2013e22","journal-title":"Am J Med"},{"key":"1484_CR5","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/S0140-6736(09)60697-8","volume":"373","author":"KK Ray","year":"2009","unstructured":"Ray KK, Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D et al (2009) Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 373:1765\u20131772","journal-title":"Lancet"},{"key":"1484_CR6","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1056\/NEJMoa0706245","volume":"358","author":"P Gaede","year":"2008","unstructured":"Gaede P, Lund-Andersen H, Parving HH, Pedersen O (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358:580\u2013591","journal-title":"N Engl J Med"},{"key":"1484_CR7","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12933-015-0283-3","volume":"14","author":"J Kuhl","year":"2015","unstructured":"Kuhl J, Jorneskog G, Wemminger M, Bengtsson M, Lundman P, Kalani M (2015) Long-term clinical outcome in patients with acute coronary syndrome and dysglycaemia. Cardiovasc Diabetol 14:120","journal-title":"Cardiovasc Diabetol"},{"key":"1484_CR8","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1053\/euhj.1999.1961","volume":"21","author":"K Thygesen","year":"2000","unstructured":"Thygesen K, Alpert JS (2000) Myocardial infarction redefined\u2014a consensus document of The Joint European Society of Cardiology\/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 21:1502\u20131513","journal-title":"Eur Heart J"},{"issue":"Suppl B","key":"1484_CR9","doi-asserted-by":"publisher","first-page":"81B","DOI":"10.1016\/S0828-282X(06)70991-6","volume":"22","author":"R Virmani","year":"2006","unstructured":"Virmani R, Burke AP, Kolodgie F (2006) Morphological characteristics of coronary atherosclerosis in diabetes mellitus. Can J Cardiol 22(Suppl B):81B\u201384B","journal-title":"Can J Cardiol"},{"key":"1484_CR10","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.113.001878","volume":"128","author":"JS Burchfield","year":"2013","unstructured":"Burchfield JS, Xie M, Hill JA (2013) Pathological ventricular remodeling: mechanisms: part 1 of 2. Circulation 128:388\u2013400","journal-title":"Circulation"},{"key":"1484_CR11","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.2337\/dci15-0012","volume":"38","author":"CS Fox","year":"2015","unstructured":"Fox CS, Golden SH, Anderson C, Bray GA, Burke LE, de Boer IH et al (2015) Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 38:1777\u20131803","journal-title":"Diabetes Care"},{"key":"1484_CR12","doi-asserted-by":"publisher","first-page":"pii:e004144","DOI":"10.1161\/JAHA.116.004144","volume":"6","author":"A Kucharska-Newton","year":"2017","unstructured":"Kucharska-Newton A, Griswold M, Yao ZH, Foraker R, Rose K, Rosamond W et al (2017) Cardiovascular disease and patterns of change in functional status over 15\u00a0years: Findings from the Atherosclerosis Risk in Communities (ARIC) Study. J Am Heart Assoc 6:pii:e004144","journal-title":"J Am Heart Assoc"},{"key":"1484_CR13","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/CIRCRESAHA.115.307611","volume":"118","author":"W Herrington","year":"2016","unstructured":"Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S (2016) Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease. Circ Res 118:535\u2013546","journal-title":"Circ Res"},{"key":"1484_CR14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.arcmed.2015.06.006","volume":"46","author":"S Barquera","year":"2015","unstructured":"Barquera S, Pedroza-Tob\u00edas A, Medina C, Hern\u00e1ndez-Barrera L, Bibbins-Domingo K, Lozano R et al (2015) Global overview of the epidemiology of atherosclerotic cardiovascular disease. Arch Med Res 46:328\u2013338","journal-title":"Arch Med Res"},{"key":"1484_CR15","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.cmet.2016.11.013","volume":"24","author":"P Libby","year":"2016","unstructured":"Libby P (2016) Assisted living in the atheroma: elderly macrophages promote plaques. Cell Metab 24:779\u2013781","journal-title":"Cell Metab"},{"key":"1484_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cmet.2011.12.006","volume":"15","author":"I Shimizu","year":"2012","unstructured":"Shimizu I, Yoshida Y, Katsuno T, Tateno K, Okada S, Moriya J et al (2012) p53-induced adipose tissue inflammation is critically involved in the development of insulin resistance in heart failure. Cell Metab 15:51\u201364","journal-title":"Cell Metab"},{"key":"1484_CR17","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","volume":"362","author":"WC Cushman","year":"2010","unstructured":"ACCORD Study Group, Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr et al (2010) Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 362:1575\u20131585","journal-title":"N Engl J Med."},{"key":"1484_CR18","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.2337\/dc14-1091","volume":"37","author":"N Li","year":"2014","unstructured":"Li N, Katzmarzyk PT, Horswell R, Zhang Y, Li W, Zhao W et al (2014) BMI and coronary heart disease risk among low-income and underinsured diabetic patients. Diabetes Care 37:3204\u20133212","journal-title":"Diabetes Care"},{"issue":"94","key":"1484_CR19","doi-asserted-by":"publisher","first-page":"e1398","DOI":"10.1097\/MD.0000000000001398","volume":"2015","author":"JF Kuo","year":"2015","unstructured":"Kuo JF, Hsieh YT, Mao IC, Lin SD, Tu ST, Hsieh MC (2015) The association between body mass index and all-cause mortality in patients with type 2 diabetes mellitus: a 5.5-year prospective analysis. Medicine (Baltimore) 2015(94):e1398","journal-title":"Medicine (Baltimore)"},{"key":"1484_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1515\/cclm-2015-0523","volume":"54","author":"F Braga","year":"2016","unstructured":"Braga F, Pasqualetti S, Ferraro S, Panteghini M (2016) Hyperuricemia as risk factor for coronary heart disease incidence and mortality in the general population: a systematic review and meta-analysis. Clin Chem Lab Med 54:7\u201315","journal-title":"Clin Chem Lab Med"},{"key":"1484_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12872-016-0379-z","volume":"16","author":"T Zuo","year":"2016","unstructured":"Zuo T, Liu X, Jiang L, Mao S, Yin X, Guo L (2016) Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studies. BMC Cardiovasc Disord 16:207","journal-title":"BMC Cardiovasc Disord"},{"key":"1484_CR22","doi-asserted-by":"publisher","first-page":"19520","DOI":"10.1038\/srep19520","volume":"6","author":"M Li","year":"2016","unstructured":"Li M, Hu X, Fan Y, Li K, Zhang X, Hou W et al (2016) Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis. Sci Rep 6:19520","journal-title":"Sci Rep"},{"key":"1484_CR23","doi-asserted-by":"publisher","first-page":"5456","DOI":"10.1038\/s41598-017-05751-w","volume":"7","author":"J Wu","year":"2017","unstructured":"Wu J, Qiu L, Cheng XQ, Xu T, Wu W, Zeng XJ et al (2017) Hyperuricemia and clustering of cardiovascular risk factors in the Chinese adult population. Sci Rep 7:5456","journal-title":"Sci Rep"},{"key":"1484_CR24","doi-asserted-by":"publisher","first-page":"e106130","DOI":"10.1371\/journal.pone.0106130","volume":"9","author":"JW Zhang","year":"2014","unstructured":"Zhang JW, He LJ, Cao SJ, Yang Q, Yang SW, Zhou YJ (2014) Association of serum uric acid and coronary artery disease in premenopausal women. PLoS ONE 9:e106130","journal-title":"PLoS ONE"},{"key":"1484_CR25","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1161\/CIRCRESAHA.114.302805","volume":"114","author":"RS Rosenson","year":"2014","unstructured":"Rosenson RS, Brewer HB, Rader DJ (2014) Lipoproteins as biomarkers and therapeutic targets in the setting of acute coronary syndrome. Circ Res 114:1880\u20131889","journal-title":"Circ Res"},{"key":"1484_CR26","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","volume":"358","author":"HC Gerstein","year":"2008","unstructured":"Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT et al (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545\u20132559","journal-title":"N Engl J Med"},{"key":"1484_CR27","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","volume":"358","author":"A Patel","year":"2008","unstructured":"ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L et al (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358:2560\u20132572","journal-title":"N Engl J Med"},{"key":"1484_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1056\/NEJMoa0808431","volume":"360","author":"W Duckworth","year":"2009","unstructured":"Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD et al (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360:129\u2013139","journal-title":"N Engl J Med"},{"key":"1484_CR29","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577\u20131589","journal-title":"N Engl J Med"},{"key":"1484_CR30","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.2337\/dc13-2727","volume":"37","author":"JI Blomster","year":"2014","unstructured":"Blomster JI, Zoungas S, Chalmers J, Li Q, Chow CK, Woodward M et al (2014) The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetes. Diabetes Care 37:1353\u20131359","journal-title":"Diabetes Care"},{"key":"1484_CR31","doi-asserted-by":"publisher","first-page":"884","DOI":"10.7326\/0003-4819-144-12-200606200-00005","volume":"144","author":"FH Messerli","year":"2006","unstructured":"Messerli FH, Mancia G, Conti CR, Hewkin AC, Kupfer S, Champion A et al (2006) Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med 144:884\u2013893","journal-title":"Ann Intern Med"},{"key":"1484_CR32","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1161\/HYPERTENSIONAHA.107.089797","volume":"50","author":"AD Protogerou","year":"2007","unstructured":"Protogerou AD, Safar ME, Iaria P, Safar H, Le Dudal K, Filipovsky J et al (2007) Diastolic blood pressure and mortality in the elderly with cardiovascular disease. Hypertension 50:172\u2013180","journal-title":"Hypertension"},{"key":"1484_CR33","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1161\/CIRCULATIONAHA.109.905687","volume":"122","author":"S Bangalore","year":"2010","unstructured":"Bangalore S, Qin J, Sloan S, Murphy SA, Cannon CP (2010) What is the optimal blood pressure in patients after acute coronary syndromes? Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trial. Circulation 122:2142\u20132151","journal-title":"Circulation"},{"key":"1484_CR34","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","volume":"31","author":"BG Nordestgaard","year":"2010","unstructured":"Nordestgaard BG, Chapman MJ, Ray K, Bor\u00e9n J, Andreotti F, Watts GF et al (2010) Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 31:2844\u20132853","journal-title":"Eur Heart J"},{"issue":"25 Suppl 2","key":"1484_CR35","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","volume":"129","author":"NJ Stone","year":"2014","unstructured":"Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH et al (2014) 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation 129(25 Suppl 2):S1\u2013S45","journal-title":"Circulation"},{"key":"1484_CR36","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1001\/jama.2009.1063","volume":"302","author":"S Erqou","year":"2009","unstructured":"Emerging\u00a0Risk\u00a0Factors Collaboration, Erqou S, Kaptoge S, Perry PL, Di Angelantonio E, Thompson A et al (2009) Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 302:412\u2013423","journal-title":"JAMA"},{"key":"1484_CR37","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1161\/CIRCULATIONAHA.107.715698","volume":"117","author":"PR Kamstrup","year":"2008","unstructured":"Kamstrup PR, Benn M, Tybj\u00e6rg-Hansen A, Nordestgaard BG (2008) Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study. Circulation 117:176\u2013184","journal-title":"Circulation"},{"key":"1484_CR38","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1001\/jama.2009.801","volume":"301","author":"PR Kamstrup","year":"2009","unstructured":"Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG (2009) Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 301:2331\u20132339","journal-title":"JAMA"},{"key":"1484_CR39","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","volume":"361","author":"R Clarke","year":"2009","unstructured":"Clarke R, Peden JF, Hopewell JC, Kyriakou T, Goel A, Heath SC et al (2009) Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med 361:2518\u20132528","journal-title":"N Engl J Med"},{"key":"1484_CR40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1161\/CIRCULATIONAHA.116.022335","volume":"134","author":"AM Perak","year":"2016","unstructured":"Perak AM, Ning H, de Ferranti SD, Gooding HC, Wilkins JT, Lloyd-Jones DM (2016) Long-term risk of atherosclerotic cardiovascular disease in US adults with the familial hypercholesterolemia phenotype. Circulation 134:9\u201319","journal-title":"Circulation"},{"key":"1484_CR41","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.jacc.2014.01.063","volume":"63","author":"R Alonso","year":"2014","unstructured":"Alonso R, Andres E, Mata N, Fuentes-Jim\u00e9nez F, Badim\u00f3n L, L\u00f3pez-Miranda J et al (2014) Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation. J Am Coll Cardiol 63:1982\u20131989","journal-title":"J Am Coll Cardiol"},{"key":"1484_CR42","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.ijcard.2015.08.146","volume":"201","author":"DC Chan","year":"2015","unstructured":"Chan DC, Pang J, Hooper AJ, Burnett JR, Bell DA, Bates TR et al (2015) Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia. Int J Cardiol 201:633\u2013638","journal-title":"Int J Cardiol"},{"key":"1484_CR43","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.14120","author":"BA Ference","year":"2019","unstructured":"Ference BA, Bhatt DL, Catapano AL, Packard CJ, Graham I, Kaptoge S et al (2019) Association of genetic variants related to combined exposure to lower low-density lipoproteins and lower systolic blood pressure with lifetime risk of\u00a0cardiovascular disease. JAMA. https:\/\/doi.org\/10.1001\/jama.2019.14120","journal-title":"JAMA"},{"key":"1484_CR44","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1161\/ATVBAHA.118.312028","volume":"39","author":"LE Larsen","year":"2019","unstructured":"Larsen LE, Stoekenbroek RM, Kastelein JJP, Holleboom AG (2019) Moving targets: recent advances in lipid-lowering therapies. Arterioscler Thromb Vasc Biol 39:349\u2013359","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-020-01484-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-020-01484-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-020-01484-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,31]],"date-time":"2021-01-31T00:21:02Z","timestamp":1612052462000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-020-01484-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,1]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1484"],"URL":"https:\/\/doi.org\/10.1007\/s00592-020-01484-x","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,1]]},"assertion":[{"value":"27 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The ethics committee of the First Affiliated Hospital of Xi\u2019an Jiaotong University approved the study (Reference Number: XJTU1AF2019LSK-064). This study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A written informed consent was obtained from all participants.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}